Refresher Courses: Hybrid, Molecular and Translational Imaging
RC 406 - Imaging-guided theranostics: current clinical practice and recent developments
Lectures
1
Chairperson's introduction
05:00Jose Luis Vercher Conejero, Barcelona / ES
2
Prostate-specific membrane antigen (PSMA)-based theranostics: prostate cancer and beyond
15:00Tobias Maurer, Hamburg / DE
3
Somatostatin receptor (SSR)-based theranostics: neuroendocrine tumours and beyond
15:00Irene Virgolini, Innsbruck / AT
4
Recent developments in the field of imaging-guided theranostics
15:00Désirée Deandreis, Villejuif / FR
5
Panel discussion: The role of radiologists in oncologic therapy
10:00Panel discussion: The role of radiologists in oncologic therapy
5 min
Chairperson's introduction
Jose Luis Vercher Conejero, Barcelona / Spain
15 min
Prostate-specific membrane antigen (PSMA)-based theranostics: prostate cancer and beyond
Tobias Maurer, Hamburg / Germany
1. To become familiar with PSMA-based radiopharmaceuticals.
2. To become familiar with clinical indications for PSMA-targeted radioligand therapy.
3. To understand the role of hybrid imaging in therapy planning and response assessment.
2. To become familiar with clinical indications for PSMA-targeted radioligand therapy.
3. To understand the role of hybrid imaging in therapy planning and response assessment.
15 min
Somatostatin receptor (SSR)-based theranostics: neuroendocrine tumours and beyond
Irene Virgolini, Innsbruck / Austria
1. To become familiar with SSR-based radiopharmaceuticals.
2. To become familiar with clinical indications for SSR-based peptide receptor radionuclide therapy.
3. To understand the role of hybrid imaging in therapy planning and response assessment.
2. To become familiar with clinical indications for SSR-based peptide receptor radionuclide therapy.
3. To understand the role of hybrid imaging in therapy planning and response assessment.
15 min
Recent developments in the field of imaging-guided theranostics
Désirée Deandreis, Villejuif / France
1. To understand basic concepts of imaging-guided theranostics.
2. To get insight into current clinical research directions.
3. To discuss future applications of imaging-guided theranostics.
2. To get insight into current clinical research directions.
3. To discuss future applications of imaging-guided theranostics.
10 min
Panel discussion: The role of radiologists in oncologic therapy